Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Applying to Laura and Isaac Perlmutter Cancer Center at NYU Langone · New York, New York
Answer a few short questions to share with the research team.